Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
1
25%
Ph phase_4
1
25%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
Phase 41 (25.0%)

Trials by Status

unknown125%
completed250%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_2

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

NCT05749822
unknownphase_4

Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

NCT04140201
completedphase_2

A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

NCT02354976
completedphase_3

Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia

NCT01878227

Clinical Trials (4)

Showing 4 of 4 trials
NCT05749822Phase 2

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

Recruiting
NCT04140201Phase 4

Effect of Lipid Lowering Agents on Diabetic Retinopathy and Cardiovascular Risk of Diabetic Patients

Unknown
NCT02354976Phase 2

A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.

Completed
NCT01878227Phase 3

Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4